SWIMMING PERFORMANCE, VENOUS OXYGEN-TENSION AND CARDIAC-PERFORMANCE OF CORONARY-LIGATED RAINBOW-TROUT, ONCORHYNCHUS-MYKISS, EXPOSED TO PROGRESSIVE HYPOXIA
Jf. Steffensen et Ap. Farrell, SWIMMING PERFORMANCE, VENOUS OXYGEN-TENSION AND CARDIAC-PERFORMANCE OF CORONARY-LIGATED RAINBOW-TROUT, ONCORHYNCHUS-MYKISS, EXPOSED TO PROGRESSIVE HYPOXIA, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology, 119(2), 1998, pp. 585-592
We performed in vivo studies to examine the idea that cardiac work is
impaired in rainbow trout (Oncorhynchus mykiss) below a certain venous
Po-2 threshold. We hypothesized that coronary-ligated fish, swimming
continuously at a reasonably high water velocity (1.5 body lengths.s(-
1)) and exposed to progressive hypoxia, would fatigue at higher venous
Po-2 and ambient water Po-2 compared with sham-operated fish. However
, we found that both the lowest venous Po-2 that supported hypoxic swi
mming (9.9 torr for coronary-ligated fish and 11.1 torr for sham-opera
ted fish) and the venous Po-2 at fatigue (7.8 torr and 8.6 torr, respe
ctively) were the same for coronary ligated and sham-operated fish. Al
so, both groups quit swimming at the same water Po-2, heart rare and h
ematocrit. Nevertheless, significant differences in cardiac performanc
e did exist between the two groups. Whereas ventral aortic blood press
ure (P-va) increased significantly with hypoxic swimming in sham-opera
ted fish, there was no such increase in coronary-ligated fish. In addi
tion, cardiac arrhythmias occurred in coronary-ligated fish at fatigue
, and these fish were slower to recover from exhaustion. We believe th
at the venous Po-2 threshold to support cardiac performance in the abs
ence of a coronary supply was between 7.8 and 9.9 torr. Furthermore, w
e suspect that the low P-va in coronary-ligated fish effectively lower
ed their myocardial O-2 demand. Uncertainty still exists regarding whe
ther or not the venous Po-2 threshold lies between 8.6 and 11.1 torr i
n sham-operated fish. (C) 1998 Elsevier Science Inc.